Intercept Pharmaceuticals, Inc.

AMERIPRISE FINANCIAL INC

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

12,399

Value ($000)

241

Weight

0.0%

2013 Q4 - 2023 Q3 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	241	0.0%	12,399	9/30/2023
2023 Q2	8/14/2023	545	0.0%	49,269	6/30/2023
2023 Q1	5/22/2023	580	0.0%	43,214	3/31/2023
2022 Q4	2/14/2023	510	0.0%	41,700	12/31/2022
2022 Q3	11/14/2022	1,244	0.0%	89,193	9/30/2022
2022 Q2	8/15/2022	1,314	0.0%	95,111	6/30/2022
2022 Q1	5/16/2022	1,418	0.0%	87,121	3/31/2022
2021 Q4	2/14/2022	1,265	0.0%	77,693	12/31/2021
2021 Q3	11/15/2021	305	0.0%	20,525	9/30/2021
2021 Q2	8/16/2021	881	0.0%	44,118	6/30/2021
2021 Q1	5/17/2021	540	0.0%	23,409	3/31/2021
2020 Q4	2/12/2021	29,900	0.0%	1,210,532	12/31/2020
2020 Q3	11/16/2020	35,709	0.0%	861,278	9/30/2020
2020 Q2	8/14/2020	8,010	0.0%	167,198	6/30/2020
2020 Q1	5/15/2020	24,995	0.0%	397,034	3/31/2020
2019 Q4	2/14/2020	33,115	0.0%	267,230	12/31/2019
2014 Q1	5/14/2014	5,936	0.0%	18,002	3/31/2014
2013 Q4	2/14/2014	1,069	0.0%	15,649	12/31/2013